MXPA01013323A - Agonistas del receptor de tiofeno a2a. - Google Patents

Agonistas del receptor de tiofeno a2a.

Info

Publication number
MXPA01013323A
MXPA01013323A MXPA01013323A MXPA01013323A MXPA01013323A MX PA01013323 A MXPA01013323 A MX PA01013323A MX PA01013323 A MXPA01013323 A MX PA01013323A MX PA01013323 A MXPA01013323 A MX PA01013323A MX PA01013323 A MXPA01013323 A MX PA01013323A
Authority
MX
Mexico
Prior art keywords
thiophene
receptor agonists
disclosed
purposes
alkylthienyl
Prior art date
Application number
MXPA01013323A
Other languages
English (en)
Inventor
Venkata P Palle
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of MXPA01013323A publication Critical patent/MXPA01013323A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA01013323A 1999-06-22 2000-06-20 Agonistas del receptor de tiofeno a2a. MXPA01013323A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22
PCT/US2000/016856 WO2000078776A2 (en) 1999-06-22 2000-06-20 Thiophene a2a receptor agonists

Publications (1)

Publication Number Publication Date
MXPA01013323A true MXPA01013323A (es) 2003-10-15

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01013323A MXPA01013323A (es) 1999-06-22 2000-06-20 Agonistas del receptor de tiofeno a2a.

Country Status (19)

Country Link
US (1) US6440948B1 (es)
EP (1) EP1194441B1 (es)
JP (1) JP2003502434A (es)
KR (1) KR100463694B1 (es)
CN (1) CN1166677C (es)
AT (1) ATE252595T1 (es)
AU (1) AU768530B2 (es)
BR (1) BR0011853A (es)
CA (1) CA2373410C (es)
DE (1) DE60006116T2 (es)
ES (1) ES2206259T3 (es)
HK (1) HK1048821B (es)
IL (2) IL147194A0 (es)
MX (1) MXPA01013323A (es)
NO (1) NO20016242L (es)
NZ (1) NZ516336A (es)
TR (1) TR200200617T2 (es)
WO (1) WO2000078776A2 (es)
ZA (1) ZA200200299B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347512C (en) * 1998-10-16 2005-12-06 Pfizer Inc. Adenine derivatives
CN1279984C (zh) 2002-02-15 2006-10-18 Cv医药有限公司 用于医用装置的聚合物涂层
TWI346109B (en) 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
DE602005020286D1 (de) * 2004-05-26 2010-05-12 Inotek Pharmaceuticals Corp Purinderivate als adenosin a 1 rezeptoragonisten und anwendungsverfahren dafür
AU2005286946B2 (en) * 2004-09-20 2012-03-15 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
WO2007064795A2 (en) * 2005-11-30 2007-06-07 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
JP2013516495A (ja) 2010-01-11 2013-05-13 イノテック ファーマシューティカルズ コーポレイション 眼圧を低下させる組合せ、キット、および方法
JP2013523739A (ja) 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション Ｎ６−シクロペンチルアデノシン（ｃｐａ）、ｃｐａ誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法
BR112014018413A8 (pt) 2012-01-26 2017-07-11 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de metila [(2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-diidroxitetraidrofuran-2-il)] e processos de preparação do mesmo
CN105188714A (zh) 2013-03-15 2015-12-23 伊诺泰克制药公司 眼用配制品
TWI823085B (zh) 2017-01-13 2023-11-21 日商東菱藥品工業股份有限公司 嗜中性白血球活化調節劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (es) * 1972-05-15 1974-02-01
JPS5518625B2 (es) * 1973-07-26 1980-05-20
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
ES2078654T3 (es) * 1991-04-06 1995-12-16 Astra Pharma Prod Analogos de atp.

Also Published As

Publication number Publication date
US6440948B1 (en) 2002-08-27
IL147194A (en) 2007-08-19
TR200200617T2 (tr) 2002-06-21
BR0011853A (pt) 2002-04-30
WO2000078776A3 (en) 2001-06-28
DE60006116D1 (de) 2003-11-27
ES2206259T3 (es) 2004-05-16
KR20020028912A (ko) 2002-04-17
NO20016242L (no) 2002-02-21
CA2373410C (en) 2006-08-29
DE60006116T2 (de) 2004-07-08
ZA200200299B (en) 2003-08-27
EP1194441B1 (en) 2003-10-22
HK1048821A1 (en) 2003-04-17
AU768530B2 (en) 2003-12-18
CN1166677C (zh) 2004-09-15
HK1048821B (zh) 2005-02-25
JP2003502434A (ja) 2003-01-21
IL147194A0 (en) 2002-08-14
WO2000078776A2 (en) 2000-12-28
NO20016242D0 (no) 2001-12-19
AU5625100A (en) 2001-01-09
KR100463694B1 (ko) 2004-12-29
ATE252595T1 (de) 2003-11-15
CN1364170A (zh) 2002-08-14
NZ516336A (en) 2004-01-30
EP1194441A2 (en) 2002-04-10
CA2373410A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
CA2377746A1 (en) N-pyrazole a2a receptor agonists
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
ZA200200299B (en) Thiophene A2A receptor agonists.
TNSN99191A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2375385A1 (en) Propargyl phenyl ether a2a receptor agonists
MY148937A (en) Medicaments with hm74a receptor activity
DK0975595T3 (da) Kokainanaloger
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
TR200201001T2 (tr) Pürin türevleri
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
DE50211929D1 (en) Pyrimidinderivate
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
PL335016A1 (en) Novel polymorph of 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl]-1-phtalazine acetic acid monohydrate, method of obtaining same, method of obtaining anhydrous 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl-1-phtalazine acetic acid, therapeutic methods, pharmaceutic agent, application of said polymorph in production of such pharmaceutic agent and method of obtaining the last mentioned one
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
UA74421C2 (uk) Похідні індолону, які є антагоністами gal3 рецептора для лікування депресії і/або тривоги та композиції, придатні для такого лікування
CA2304821A1 (en) Osteoblast-specific mitogens and drugs containing such compounds
DE60008589D1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten
EP1254120A1 (en) Use of pyrimidine endothelin antagonists in companion animals
EP0370821A3 (en) 1,4-dihydropyridine derivatives

Legal Events

Date Code Title Description
FG Grant or registration